zinc chloride 🐶 Veterinary Use | Indications/Contra | FAERs-F | FAERs-M | Orange Bk | BioActivity |

Stem definitionDrug idCAS RN
4344 7646-85-7

Description:

MoleculeDescription

Synonyms:

  • zinc chloride
  • zinc dichloride
  • Molecular weight: 136.28
  • Formula: Cl2Zn
  • CLOGP:
  • LIPINSKI: None
  • HAC: None
  • HDO: None
  • TPSA:
  • ALOGS:
  • ROTB: None

Drug dosage:

None

ADMET properties:

None

Approvals:

DateAgencyCompanyOrphan
June 26, 1986 FDA HOSPIRA

FDA Adverse Event Reporting System (Female)

MedDRA adverse event termLikelihood ratioLikelihood ratio thresholdPatients taking drug having adverse eventPatients taking drug not having adverse eventPatients not taking drug having adverse eventPatients not taking drug not having adverse event
Sedation complication 493.46 12.29 191 24978 13631 63450222
Creatinine renal clearance decreased 466.24 12.29 192 24977 16116 63447737
Blood calcium decreased 403.82 12.29 201 24968 26250 63437603
Orthostatic hypotension 336.87 12.29 198 24971 35962 63427891
Sedation 323.91 12.29 198 24971 38611 63425242
Cognitive disorder 294.47 12.29 214 24955 55601 63408252
Depressed level of consciousness 244.26 12.29 200 24969 61878 63401975
Balance disorder 243.70 12.29 228 24941 84194 63379659
Mobility decreased 193.26 12.29 239 24930 120920 63342933
Gastrointestinal toxicity 180.79 12.29 79 25090 7662 63456191
Constipation 176.55 12.29 318 24851 224625 63239228
Pulmonary toxicity 162.62 12.29 78 25091 9377 63454476
Methaemoglobinaemia 125.63 12.29 44 25125 2359 63461494
Joint injury 105.29 12.29 90 25079 29482 63434371
COVID-19 100.38 12.29 169 25000 112934 63350919
Neoplasm malignant 98.48 12.29 87 25082 29774 63434079
Hepatotoxicity 82.57 12.29 87 25082 36954 63426899
Fall 77.44 12.29 334 24835 392000 63071853
Macular degeneration 68.62 12.29 65 25104 24311 63439542
Pemphigus 57.32 12.29 4 25165 183722 63280131
Joint stiffness 56.30 12.29 76 25093 41793 63422060
Hypotension 55.94 12.29 235 24934 272369 63191484
C-reactive protein abnormal 49.24 12.29 75 25094 46021 63417832
Synovitis 48.38 12.29 8 25161 186910 63276943
Pulmonary pain 45.88 12.29 24 25145 3466 63460387
Systemic lupus erythematosus 45.85 12.29 13 25156 208905 63254948
Pain 44.89 12.29 469 24700 740159 62723694
Toxicity to various agents 43.77 12.29 204 24965 247046 63216807
Necrosis ischaemic 42.11 12.29 15 25154 845 63463008
Therapy non-responder 40.99 12.29 92 25077 75809 63388044
Glossodynia 39.48 12.29 11 25158 178865 63284988
Maternal exposure during pregnancy 39.37 12.29 19 25150 220043 63243810
Multiple drug therapy 39.35 12.29 22 25147 3624 63460229
Salpingo-oophorectomy unilateral 38.03 12.29 14 25155 867 63462986
Death 38.01 12.29 56 25113 374325 63089528
Chronic sinusitis 37.58 12.29 35 25134 12808 63451045
Hand deformity 36.73 12.29 9 25160 159448 63304405
Amyloid arthropathy 35.69 12.29 12 25157 568 63463285
Copper deficiency 35.52 12.29 8 25161 80 63463773
Pericarditis 35.48 12.29 5 25164 131574 63332279
Illness 35.37 12.29 67 25102 48992 63414861
Therapeutic product effect incomplete 34.00 12.29 118 25051 124938 63338915
Aplastic anaemia 33.79 12.29 29 25140 9540 63454313
Beta haemolytic streptococcal infection 32.68 12.29 16 25153 2009 63461844
Anti-cyclic citrullinated peptide antibody positive 32.33 12.29 4 25165 116208 63347645
Musculoskeletal pain 31.36 12.29 94 25075 92183 63371670
Pneumonia streptococcal 31.31 12.29 15 25154 1796 63462057
Sinusitis fungal 31.16 12.29 15 25154 1816 63462037
Female genital tract fistula 31.04 12.29 25 25144 7534 63456319
Skin odour abnormal 29.42 12.29 14 25155 1652 63462201
Contraindicated product administered 29.17 12.29 26 25143 217622 63246231
Acute kidney injury 27.10 12.29 39 25130 263376 63200477
Nasal polyps 27.00 12.29 21 25148 6018 63457835
Sputum increased 26.98 12.29 15 25154 2444 63461409
Lipoedema 25.84 12.29 8 25161 290 63463563
Dermatitis atopic 25.60 12.29 25 25144 9699 63454154
Respiratory symptom 25.17 12.29 16 25153 3331 63460522
Wound secretion 24.99 12.29 18 25151 4596 63459257
Discomfort 23.64 12.29 19 25150 167355 63296498
Arthritis infective 23.63 12.29 20 25149 6458 63457395
Embolism venous 23.52 12.29 15 25154 3139 63460714
Spinal cord disorder 23.34 12.29 11 25158 1270 63462583
Norovirus infection 22.97 12.29 9 25160 661 63463192
Paraesthesia oral 22.96 12.29 33 25136 19223 63444630
Acquired diaphragmatic eventration 22.57 12.29 8 25161 444 63463409
Wound 22.48 12.29 19 25150 163244 63300609
Procedural complication 22.36 12.29 18 25151 5421 63458432
Rhinocerebral mucormycosis 22.35 12.29 8 25161 457 63463396
Duodenal ulcer perforation 21.96 12.29 4 25165 87205 63376648
Eczema 21.92 12.29 43 25126 32248 63431605
Product dose omission issue 21.65 12.29 163 25006 234150 63229703
White blood cell count decreased 21.16 12.29 110 25059 138994 63324859
Rheumatoid factor positive 20.98 12.29 4 25165 84402 63379451
Infrapatellar fat pad inflammation 20.90 12.29 6 25163 167 63463686
Drug hypersensitivity 20.24 12.29 200 24969 310487 63153366
Cardiac arrest 19.84 12.29 6 25163 92539 63371314
Diastolic dysfunction 19.64 12.29 18 25151 6453 63457400
Fistula discharge 18.74 12.29 9 25160 1084 63462769
Terminal insomnia 18.25 12.29 8 25161 781 63463072
Thrombocytopenia 18.01 12.29 20 25149 151137 63312716
Yellow skin 17.40 12.29 11 25158 2269 63461584
Product use issue 16.99 12.29 39 25130 220481 63243372
General physical health deterioration 16.86 12.29 34 25135 201368 63262485
Heart rate variability increased 16.52 12.29 4 25165 56 63463797
Appetite disorder 15.96 12.29 17 25152 7304 63456549
Gastrointestinal candidiasis 15.95 12.29 5 25164 189 63463664
Eyelid margin crusting 15.91 12.29 8 25161 1064 63462789
Confusional state 15.75 12.29 45 25124 236335 63227518
Infusion site extravasation 15.67 12.29 20 25149 10406 63453447
Intentional overdose 15.55 12.29 5 25164 74147 63389706
Hyponatraemia 15.42 12.29 13 25156 111887 63351966
Chest discomfort 15.38 12.29 85 25084 109884 63353969
Pain in extremity 15.08 12.29 199 24970 331287 63132566
Drug interaction 14.99 12.29 44 25125 229087 63234766
Emphysema 14.92 12.29 20 25149 10918 63452935
Effusion 14.91 12.29 9 25160 1709 63462144
Fear of falling 14.90 12.29 6 25163 474 63463379
Chondropathy 14.86 12.29 10 25159 2290 63461563
Haemorrhagic diathesis 14.82 12.29 13 25156 4402 63459451
Feeling abnormal 14.70 12.29 105 25064 148287 63315566
Blood smear test abnormal 14.30 12.29 4 25165 101 63463752
Folliculitis 14.30 12.29 5 25164 70312 63393541
Tenderness 14.05 12.29 29 25140 22549 63441304
Endometrial cancer 13.96 12.29 11 25158 3214 63460639
Hysterectomy 13.93 12.29 18 25151 9481 63454372
Procedural pain 13.77 12.29 28 25141 21541 63442312
Product dose omission in error 13.71 12.29 16 25153 7596 63456257
Seasonal allergy 13.14 12.29 27 25142 20923 63442930
Disease recurrence 12.97 12.29 32 25137 27998 63435855
Ocular icterus 12.75 12.29 11 25158 3645 63460208
Scar 12.74 12.29 21 25148 13761 63450092
Candida infection 12.73 12.29 32 25137 28319 63435534
Muscle injury 12.69 12.29 5 25164 65340 63398513
Musculoskeletal stiffness 12.57 12.29 120 25049 184498 63279355
Spleen atrophy 12.53 12.29 3 25166 40 63463813
Helicobacter infection 12.52 12.29 11 25158 92774 63371079
Exposure during pregnancy 12.39 12.29 27 25142 155520 63308333
Thinking abnormal 12.34 12.29 18 25151 10625 63453228

FDA Adverse Event Reporting System (Male)

MedDRA adverse event termLikelihood ratioLikelihood ratio thresholdPatients taking drug having adverse eventPatients taking drug not having adverse eventPatients not taking drug having adverse eventPatients not taking drug not having adverse event
Methaemoglobinaemia 135.20 14.75 45 8137 3536 34945213
Off label use 71.22 14.75 237 7945 419287 34529462
Rhinocerebral mucormycosis 56.03 14.75 15 8167 553 34948196
COVID-19 51.19 14.75 76 8106 77474 34871275
Radiation inflammation 40.74 14.75 13 8169 892 34947857
Pulmonary pain 36.89 14.75 13 8169 1211 34947538
Product dose omission issue 30.03 14.75 78 8104 119633 34829116
Fatigue 22.59 14.75 156 8026 370497 34578252
Copper deficiency 22.45 14.75 4 8178 19 34948730
Aplastic anaemia 21.53 14.75 18 8164 9698 34939051
Conjunctival scar 20.21 14.75 5 8177 134 34948615
Sinusitis 17.16 14.75 33 8149 41369 34907380
Product preparation error 16.83 14.75 9 8173 2308 34946441
Metal poisoning 16.75 14.75 4 8178 92 34948657
Vascular device infection 16.59 14.75 11 8171 4174 34944575
Haemolysis 15.91 14.75 14 8168 8080 34940669
Arthropathy 15.79 14.75 25 8157 26882 34921867

FDA Adverse Event Reporting System (Geriatric)

MedDRA adverse event termLikelihood ratioLikelihood ratio thresholdPatients taking drug having adverse eventPatients taking drug not having adverse eventPatients not taking drug having adverse eventPatients not taking drug not having adverse event
Sedation complication 513.71 12.03 195 26820 15474 79701899
Creatinine renal clearance decreased 480.64 12.03 196 26819 18806 79698567
Blood calcium decreased 416.20 12.03 207 26808 31612 79685761
Sedation 316.76 12.03 205 26810 51690 79665683
Orthostatic hypotension 299.61 12.03 204 26811 55960 79661413
Cognitive disorder 292.47 12.03 219 26796 69707 79647666
Methaemoglobinaemia 244.68 12.03 86 26929 5471 79711902
Balance disorder 237.77 12.03 225 26790 98632 79618741
Mobility decreased 216.92 12.03 236 26779 121939 79595434
Depressed level of consciousness 202.49 12.03 204 26811 96448 79620925
Constipation 164.90 12.03 322 26693 282728 79434645
COVID-19 128.62 12.03 208 26807 157466 79559907
Pulmonary pain 82.76 12.03 37 26978 4436 79712937
Pain 81.64 12.03 460 26555 703342 79014031
Rhinocerebral mucormycosis 73.08 12.03 23 26992 1035 79716338
Gastrointestinal toxicity 67.24 12.03 39 26976 8070 79709303
Fall 66.16 12.03 333 26682 487296 79230077
Pulmonary toxicity 55.15 12.03 41 26974 12873 79704500
Off label use 49.89 12.03 497 26518 906718 78810655
Copper deficiency 48.50 12.03 11 27004 135 79717238
Aplastic anaemia 45.36 12.03 42 26973 17863 79699510
Joint injury 42.87 12.03 53 26962 31282 79686091
Chronic sinusitis 41.91 12.03 35 26980 12991 79704382
Product dose omission issue 41.52 12.03 180 26835 247357 79470016
Necrosis ischaemic 40.94 12.03 15 27000 1075 79716298
Salpingo-oophorectomy unilateral 40.93 12.03 14 27001 820 79716553
Multiple drug therapy 40.28 12.03 22 26993 4056 79713317
Hypotension 40.25 12.03 271 26744 440046 79277327
Female genital tract fistula 39.88 12.03 25 26990 5950 79711423
Nasal polyps 37.57 12.03 26 26989 7301 79710072
Amyloid arthropathy 37.54 12.03 12 27003 568 79716805
Acute kidney injury 36.34 12.03 76 26939 519328 79198045
Radiation inflammation 36.02 12.03 13 27002 892 79716481
Illness 34.69 12.03 59 26956 46452 79670921
Macular degeneration 33.57 12.03 29 26986 11267 79706106
Neoplasm malignant 33.02 12.03 47 26968 31763 79685610
Beta haemolytic streptococcal infection 31.46 12.03 15 27000 2082 79715291
Skin odour abnormal 31.17 12.03 15 27000 2126 79715247
Pneumonia streptococcal 30.46 12.03 16 26999 2729 79714644
Synovitis 30.19 12.03 7 27008 150727 79566646
Sinusitis fungal 29.70 12.03 15 27000 2359 79715014
Paraesthesia oral 25.43 12.03 33 26982 20438 79696935
Sputum increased 25.14 12.03 17 26998 4596 79712777
Conjunctival scar 24.97 12.03 7 27008 210 79717163
Acquired diaphragmatic eventration 24.51 12.03 9 27006 649 79716724
Coma 23.82 12.03 3 27012 100646 79616727
Death 23.73 12.03 105 26910 566409 79150964
Respiratory symptom 22.24 12.03 16 26999 4775 79712598
Joint stiffness 21.94 12.03 45 26970 40785 79676588
Drug interaction 21.90 12.03 70 26945 415113 79302260
Infrapatellar fat pad inflammation 21.83 12.03 6 27009 167 79717206
Embolism venous 21.63 12.03 15 27000 4224 79713149
Cardiac failure 21.35 12.03 13 27002 154829 79562544
Pemphigus 21.22 12.03 4 27011 99578 79617795
Lipoedema 20.35 12.03 6 27009 216 79717157
Norovirus infection 20.34 12.03 8 27007 696 79716677
Arthritis infective 20.18 12.03 19 26996 8252 79709121
Systemic lupus erythematosus 19.98 12.03 8 27007 121141 79596232
Toxic anterior segment syndrome 19.55 12.03 12 27003 2752 79714621
Intentional overdose 19.18 12.03 6 27009 105954 79611419
Chest discomfort 19.14 12.03 95 26920 137949 79579424
Pericarditis 18.69 12.03 6 27009 104230 79613143
Wound secretion 18.62 12.03 16 26999 6172 79711201
Hysterectomy 18.43 12.03 16 26999 6256 79711117
Toxicity to various agents 18.43 12.03 221 26794 421319 79296054
Oral pain 18.22 12.03 36 26979 31762 79685611
Fistula discharge 18.16 12.03 9 27006 1359 79716014
Eczema 17.40 12.03 41 26974 40777 79676596
Taste disorder 17.34 12.03 24 26991 15799 79701574
Hepatotoxicity 17.13 12.03 47 26968 51305 79666068
Heart rate variability increased 17.08 12.03 4 27011 57 79717316
Infusion site extravasation 16.99 12.03 19 26996 10089 79707284
Sinusitis 16.43 12.03 118 26897 195383 79521990
Anti-cyclic citrullinated peptide antibody positive 16.37 12.03 4 27011 83139 79634234
Tenderness 16.33 12.03 29 26986 23613 79693760
Angioedema 16.32 12.03 3 27012 76032 79641341
Terminal insomnia 16.14 12.03 8 27007 1209 79716164
Diastolic dysfunction 15.95 12.03 19 26996 10792 79706581
Spinal cord disorder 15.68 12.03 9 27006 1826 79715547
Appetite disorder 15.57 12.03 16 26999 7723 79709650
Chondropathy 15.49 12.03 10 27005 2502 79714871
Product preparation error 15.47 12.03 14 27001 5779 79711594
Disease recurrence 15.34 12.03 41 26974 44068 79673305
Vaginal flatulence 15.27 12.03 10 27005 2565 79714808
Seasonal allergy 15.23 12.03 23 26992 16383 79700990
Hyponatraemia 15.13 12.03 23 26992 177825 79539548
White blood cell count decreased 14.88 12.03 112 26903 188176 79529197
General physical health deterioration 14.78 12.03 46 26969 275192 79442181
Endometrial cancer 14.58 12.03 9 27006 2085 79715288
Myocardial infarction 14.55 12.03 25 26990 184104 79533269
Feeling abnormal 14.50 12.03 98 26917 159101 79558272
Maternal exposure during pregnancy 14.38 12.03 15 27000 136523 79580850
Eyelid margin crusting 14.16 12.03 7 27008 1052 79716321
Effusion 14.12 12.03 9 27006 2205 79715168
Opportunistic infection 14.03 12.03 10 27005 2940 79714433
Hand deformity 13.94 12.03 9 27006 103910 79613463
Dermatitis atopic 13.74 12.03 17 26998 10039 79707334
Scar 13.68 12.03 21 26994 15175 79702198
Fear of falling 13.66 12.03 6 27009 689 79716684
Sinus disorder 13.56 12.03 26 26989 22438 79694935
Neutropenia 13.48 12.03 51 26964 287659 79429714
Sneezing 13.41 12.03 24 26991 19659 79697714
Rhinorrhoea 13.25 12.03 56 26959 76018 79641355
Multiple allergies 13.20 12.03 17 26998 10443 79706930
SARS-CoV-2 test positive 13.19 12.03 18 26997 11698 79705675
Thrombocytopenia 13.09 12.03 46 26969 265213 79452160
Procedural pain 13.06 12.03 26 26989 23058 79694315
Gastrointestinal candidiasis 12.78 12.03 5 27010 429 79716944
Emphysema 12.58 12.03 21 26994 16279 79701094
Spleen atrophy 12.43 12.03 3 27012 49 79717324
Hepato-lenticular degeneration 12.21 12.03 3 27012 53 79717320
Leukopenia 12.05 12.03 13 27002 116500 79600873

FDA Adverse Event Reporting System (Pediatric)

None

Pharmacologic Action:

SourceCodeDescription
ATC B05XA12 BLOOD AND BLOOD FORMING ORGANS
BLOOD SUBSTITUTES AND PERFUSION SOLUTIONS
I.V. SOLUTION ADDITIVES
Electrolyte solutions
MeSH PA D003358 Cosmetics
MeSH PA D009067 Mouthwashes
CHEBI has role CHEBI:39143 Lewis acid
CHEBI has role CHEBI:48219 disinfectants
CHEBI has role CHEBI:74783 adstringent
CHEBI has role CHEBI:86385 Delta(7)-cholestenol Delta(7)-Delta(8)-isomerase inhibitors

Drug Use | Suggest Off label Use Form| |View source of the data|

DiseaseRelationSNOMED_IDDOID
Zinc deficiency indication 238124008
Local anesthesia indication 386761002
Mouth Irritation indication
Suppression of the Gag Reflex indication
Hereditary acrodermatitis enteropathica off-label use 37702000
Cerebral trauma off-label use 275382005
Hypocupremia contraindication 19577007
Methemoglobinemia contraindication 38959009 DOID:10783
Wilson's disease contraindication 88518009
Anemia due to enzyme deficiency contraindication 111577008
Deficiency of glucose-6-phosphate dehydrogenase contraindication 124134002 DOID:2862
Deficiency of cytochrome-b>5< reductase contraindication 124184009




🐶 Veterinary Drug Use

None

🐶 Veterinary products

None

Acid dissociation constants calculated using MoKa v3.0.0

None

Orange Book patent data (new drug applications)

None

Orange Book exclusivity data (new drug applications)

None

Bioactivity Summary:

TargetClassPharosUniProtActionTypeActivity value
(-log[M])		Mechanism
action		Bioact sourceMoA source
Sodium-dependent noradrenaline transporter Transporter Ki 5.16 DRUG MATRIX
Carbonic anhydrase 2 Enzyme IC50 5.94 DRUG MATRIX
Epidermal growth factor receptor Kinase IC50 5.66 DRUG MATRIX
Tyrosine-protein kinase Fyn Kinase IC50 5.73 DRUG MATRIX
Serine/threonine-protein phosphatase 2B catalytic subunit alpha isoform Enzyme IC50 5.96 DRUG MATRIX
G-protein coupled receptor 39 GPCR EC50 8.44 CHEMBL
Ubiquitin-conjugating enzyme E2 T Enzyme Kd 4.80 CHEMBL
Androgen receptor Transcription factor Ki 5.36 DRUG MATRIX
G protein-coupled receptor 39-1b GPCR EC50 5.39 CHEMBL

External reference:

IDSource
4018532 VUID
N0000146854 NUI
D02058 KEGG_DRUG
4018532 VANDF
C0078774 UMLSCUI
CHEBI:49976 CHEBI
CHEMBL1200679 ChEMBL_ID
DB14533 DRUGBANK_ID
C016837 MESH_SUPPLEMENTAL_RECORD_UI
86Q357L16B UNII
5727 PUBCHEM_CID
39937 RXNORM
1505 MMSL
5707 MMSL
d04055 MMSL
000842 NDDF
001942 NDDF

Pharmaceutical products:

ProductCategoryIngredientsNDCFormQuantityRouteMarketingLabel
4x Medicated Toothache and Gum Cream HUMAN OTC DRUG LABEL 4 0363-0607 CREAM 0.15 g ORAL OTC monograph not final 9 sections
4x Medicated Toothache and Gum Cream HUMAN OTC DRUG LABEL 4 0363-0607 CREAM 0.15 g ORAL OTC monograph not final 9 sections
3x Medicated Mouth Sore Gel HUMAN OTC DRUG LABEL 3 0363-1605 GEL 0.15 g ORAL OTC monograph not final 7 sections
3x Medicated Mouth Sore Gel HUMAN OTC DRUG LABEL 3 0363-1605 GEL 0.15 g ORAL OTC monograph not final 7 sections
PM Toothache Relief HUMAN OTC DRUG LABEL 4 0363-1623 PASTE 0.24 g DENTAL OTC monograph not final 8 sections
Walgreens Instant Toothache and Gum Relief Triple Medicated HUMAN OTC DRUG LABEL 3 0363-5350 CREAM 0.15 g TOPICAL OTC monograph not final 12 sections
Walgreens Instant Toothache and Gum ReliefTriple Medicated HUMAN OTC DRUG LABEL 3 0363-5351 GEL 0.15 g TOPICAL OTC monograph not final 12 sections
Walgreens Instant Toothache and Gum ReliefTriple Medicated HUMAN OTC DRUG LABEL 3 0363-5351 GEL 0.15 g TOPICAL OTC monograph not final 12 sections
4x Medicated Toothache and Gum Gel HUMAN OTC DRUG LABEL 4 0363-6008 GEL 0.15 g ORAL OTC monograph not final 9 sections
4x Medicated Toothache and Gum Gel HUMAN OTC DRUG LABEL 4 0363-6008 GEL 0.15 g ORAL OTC monograph not final 9 sections
ZINC HUMAN PRESCRIPTION DRUG LABEL 1 0409-4090 INJECTION, SOLUTION 1 mg INTRAVENOUS NDA 20 sections
KANKA SoftBrush HUMAN OTC DRUG LABEL 2 10157-2106 GEL 0.10 g ORAL OTC MONOGRAPH NOT FINAL 12 sections
Orajel Instant Pain ReliefMaximum Strength HUMAN OTC DRUG LABEL 3 10237-708 GEL 1 mg TOPICAL OTC monograph not final 8 sections
Orajel 3X Medicated for Denture Pain HUMAN OTC DRUG LABEL 3 10237-723 GEL 1.50 mg TOPICAL OTC monograph not final 12 sections
Orajel 3X Medicated for Denture Pain HUMAN OTC DRUG LABEL 3 10237-723 GEL 1.50 mg TOPICAL OTC monograph not final 12 sections
Orajel Toothache Rinse HUMAN OTC DRUG LABEL 2 10237-764 LIQUID 1.50 mg TOPICAL OTC monograph not final 11 sections
Orajel Toothache Rinse HUMAN OTC DRUG LABEL 2 10237-764 LIQUID 1.50 mg TOPICAL OTC monograph not final 11 sections
Orajel 3X Medicated For All Mouth Sores HUMAN OTC DRUG LABEL 3 10237-783 GEL 1.50 mg TOPICAL OTC monograph not final 12 sections
Orajel 4X Medicated For Toothache and Gum HUMAN OTC DRUG LABEL 4 10237-787 GEL 1.50 mg TOPICAL OTC monograph not final 12 sections
Orajel 4X Medicated For Toothache and Gum HUMAN OTC DRUG LABEL 4 10237-787 GEL 1.50 mg TOPICAL OTC monograph not final 12 sections
Orajel 4X Medicated PM For Toothache and Gum HUMAN OTC DRUG LABEL 4 10237-789 CREAM 1.50 mg TOPICAL OTC monograph not final 12 sections
Orajel 4X Medicated PM For Toothache and Gum HUMAN OTC DRUG LABEL 4 10237-789 CREAM 1.50 mg TOPICAL OTC monograph not final 12 sections
Orajel 3X Medicated For Toothache and Gum HUMAN OTC DRUG LABEL 3 10237-790 GEL 1.50 mg TOPICAL OTC monograph not final 12 sections
Orajel Gum Pain 3X Medicated HUMAN OTC DRUG LABEL 3 10237-792 GEL 1.50 mg TOPICAL OTC monograph not final 12 sections
Orajel Gum Pain 3X Medicated HUMAN OTC DRUG LABEL 3 10237-792 GEL 1.50 mg TOPICAL OTC monograph not final 12 sections
Rite AidMaximum Strength HUMAN OTC DRUG LABEL 3 11822-0317 GEL, DENTIFRICE 0.10 g ORAL OTC monograph not final 9 sections
3X Medicated Toothache and Gum Gel HUMAN OTC DRUG LABEL 3 11822-0613 GEL 0.15 g ORAL OTC monograph not final 11 sections
3X Medicated Toothache and Gum Gel HUMAN OTC DRUG LABEL 3 11822-0613 GEL 0.15 g ORAL OTC monograph not final 11 sections
4X Medicated Severe Toothache and Gum Cream HUMAN OTC DRUG LABEL 4 11822-0614 CREAM 0.15 g ORAL OTC monograph not final 11 sections
4X Medicated Severe Toothache and Gum Cream HUMAN OTC DRUG LABEL 4 11822-0614 CREAM 0.15 g ORAL OTC monograph not final 11 sections